Keyphrases
Hematopoietic Stem Cell Transplantation
100%
CD40 Ligand Deficiency
100%
Overall Survival
40%
Event-free Survival
30%
Disease-free Survival
30%
Myeloablative Conditioning
30%
Risk Factors
20%
Survival Events
20%
Organ Damage
20%
Supportive Therapy
20%
Survivors
10%
Transplantation
10%
T Cells
10%
Stem Cells
10%
Improved Outcomes
10%
Long-term Survival
10%
Curative Treatment
10%
International Research Collaboration
10%
Matched Donors
10%
Primary Sclerosing Cholangitis
10%
Donor Cells
10%
Chimerism
10%
Patient Management
10%
Cryptosporidium
10%
Unrelated Donor
10%
Cell Engraftment
10%
X-linked Severe Combined Immunodeficiency
10%
Myeloablative Regimen
10%
Reduced-intensity Conditioning
10%
Damage Development
10%
Immunoglobulin Replacement
10%
Pneumocystis
10%
Medicine and Dentistry
Hematopoietic Stem Cell Transplantation
100%
CD40 Ligand
100%
Overall Survival
40%
Event Free Survival
30%
Disease Free Survival
30%
Infection
20%
Myeloablative Conditioning
20%
Immunoglobulin
10%
Stem Cell
10%
T Lymphocyte
10%
Patient Care
10%
Engraftment
10%
Long Term Survival
10%
Matched Donor
10%
Prospective Study
10%
Chimera
10%
Immune Deficiency
10%
Nonmyeloablative Conditioning
10%
Reduced Intensity Conditioning
10%
Sclerosing Cholangitis
10%
Immunology and Microbiology
Hematopoietic Stem Cell Transplantation
100%
CD40 Ligand
100%
Overall Survival
40%
Event Free Survival
30%
Conditioning
30%
Disease Free Survival
30%
T Cell
10%
Stem Cell
10%
Long Term Survival
10%
Immunodeficiency
10%
Intravenous Immunoglobulin
10%
Engraftment
10%
Cryptosporidium
10%
Chimera
10%
Pneumocystis
10%